Non-small cell lung cancer (NSCLC) is the most prevalent form of lung cancer. It originates in the lungs, with cancer cells invading bronchi and lung structures like bronchioles and alveoli. Symptoms often don’t manifest until the disease reaches an advanced stage. Effective treatment involves integrating medical interventions, and that’s where we come in. Our unique therapies are designed to positively regulate the immune system, reduce inflammation, and more.
Incidence measures the rate of new cases of a disease in a specific population during a defined time period. For example, in 2018, the U.S. saw an estimated 1,735,350 new cancer cases and 609,640 cancer-related deaths.
Prevalence takes into account the number of affected individuals in a population at a specific point in time. It’s a vital metric for understanding the disease burden. Knowing these statistics guides resource allocation and risk assessment.
Lung cancer claims more lives yearly than breast, prostate, and colon cancers combined. It’s considered one of the deadliest forms of cancer. Among men, it’s the most commonly diagnosed cancer in 36 countries. It’s the leading cause of cancer death among women in 25 countries.
The Global Cancer Statistics 2020 published by the American Cancer Society covers numerous statistics on different types of cancers in men and women.
With an estimated 2.2 million new cancer cases and 1.8 million deaths, lung cancer is the second most commonly diagnosed cancer behind female breast cancer.
Among men, lung cancer is the most commonly diagnosed cancer in 36 countries and is the leading cause of male cancer death in 93 countries.
Some of the most significant incidence rates are observed in:
Among women, lung cancer is the leading cause of cancer death in 25 countries in Northern America, Oceania, and parts of Europe.
The most significant incidence rates are found in:
Survival rates vary, with only 10-20% of patients surviving five years post-diagnosis. However, rates are higher in certain regions like Japan, Israel, and The Republic of Korea.
Smoking, the primary cause of non-small cell lung cancer (NSCLC), has contributed to over 20 million lung cancer deaths in the U.S. since 1964. Secondhand smoke exposure has also resulted in significant mortality.
Tobacco control policies can significantly reduce new lung cancer cases. The World Health Organization’s MPOWER package offers six policy intervention strategies to create a conducive environment for quitting smoking and protect people from secondhand smoke.
Lung cancer doesn’t have to be a fatal diagnosis. At Miskawaan Integrative Cancer Care, we offer personalized treatments combining German and Thai expertise in complementary oncology and functional medicine. Our 360-degree integrative cancer care includes advanced diagnostic solutions for early detection and precise treatments.
Treatments Screening
Chinese